{
    "nctId": "NCT00499681",
    "briefTitle": "PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE",
    "officialTitle": "A Phase II Neo-Adjuvant Study of Letrozole in Combination With Lapatinib in Post -Menopausal Patients With HER2-Positive and Hormone Receptor-Positive Operable Breast Cancer",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 6,
    "primaryOutcomeMeasure": "Number of Participants With a Pathological Complete Response",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\nInclusion Criteria:\n\n* Clinical stage I, II, or III operable invasive mammary carcinoma, confirmed by histological analysis\n\n  * Measurable residual tumor at the primary site\n\n    * Measurable disease is defined as any mass that can be reproducibly measured by physical examination, mammogram, and/or ultrasound and can be accurately measured in at least one dimension (longest diameter to be recorded) as 10 mm (1 cm)\n* Available core biopsies from the time of diagnosis\n\n  * May include sections of paraffin-embedded material\n* Scheduled to undergo surgical treatment with either segmental resection or total mastectomy\n* Prior history of contralateral breast cancer allowed if patient has no evidence of recurrence of their initial primary breast cancer within the last 5 years\n* HER2-positive by Herceptest (3+) or FISH\n* ER-positive and/or PR-positive by IHC\n\nExclusion Criteria:\n\n* Locally recurrent breast cancer\n* Evidence of distant metastatic disease (i.e., lung, liver, bone, or brain metastases)\n\nPATIENT CHARACTERISTICS:\n\nInclusion Criteria:\n\n* Female\n* Postmenopausal, as defined by any of the following:\n\n  * At least 55 years of age\n  * Under 55 years of age and amenorrheic for at least 12 months OR follicle-stimulating hormone (FSH) values \u2265 40 IU/L and estradiol levels \u2264 20 IU/L\n  * Prior bilateral oophorectomy or prior radiation castration with amenorrhea for at least 6 months\n* ECOG performance status 0-1\n* ANC \u2265 1,000/mm\u00b3\n* Platelet count \u2265 100,000/mm\u00b3\n* Creatinine \u2264 1.5 times upper limit of normal (ULN)\n* Bilirubin \u2264 1.5 times ULN\n* AST and ALT \u2264 1.5 times ULN\n* Able to swallow and retain oral medication\n* Cardiac ejection fraction normal by echocardiogram (or MUGA scan if an echocardiogram cannot be performed or is inconclusive)\n\nExclusion Criteria:\n\n* Premenopausal breast cancer, pregnant, or lactating\n* Serious medical illness, that in the judgment of the treating physician, places the patient at high risk of operative mortality\n* Malabsorption syndrome, disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel\n* Ulcerative colitis\n* History of other malignancy\n\n  * Patients who have been disease-free for 5 years, or patients with a history of completely resected non-melanoma skin cancer or successfully treated in situ carcinomas are eligible\n* Active or uncontrolled infection\n* Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent\n* Known history of uncontrolled or symptomatic angina, arrhythmias, or congestive heart failure\n\nPRIOR CONCURRENT THERAPY:\n\nExclusion Criteria:\n\n* Prior chemotherapy for primary breast cancer\n* Tamoxifen or raloxifene as a preventive agent within the past 21 days\n* Hormone replacement therapy (e.g., conjugated estrogens tablets \\[Premarin\\]) within the past month\n* Prior therapy with anthracyclines\n* Investigational drug within the past 30 days or 5 half-lives, whichever is longer\n* Concurrent anti-cancer therapy (chemotherapy, radiation therapy, surgery, immunotherapy, hormonal therapy, or any other biologic therapy) other than letrozole\n* Concurrent treatment with an investigational agent",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}